N-(2,6-diethylphenyl)-8-[N-hydroxy-4-[(1-methylpiperidin-4-yl)carbamoyl]-2-(trifluoromethoxy)anilino]-1-methyl-4,5-dihydropyrazolo[4,5-h]quinazoline-3-carboxamide

C35H39F3N8O4 — CID 170168513

IUPACN-(2,6-diethylphenyl)-8-[N-hydroxy-4-[(1-methylpiperidin-4-yl)carbamoyl]-2-(trifluoromethoxy)anilino]-1-methyl-4,5-dihydropyrazolo[4,5-h]quinazoline-3-carboxamide
SMILESCCc1cccc(CC)c1NC(=O)c1nn(C)c2c1CCc1cnc(N(O)c3ccc(C(=O)NC4CCN(C)CC4)cc3OC(F)(F)F)nc1-2
InChIInChI=1S/C35H39F3N8O4/c1-5-20-8-7-9-21(6-2)28(20)41-33(48)30-25-12-10-23-19-39-34(42-29(23)31(25)45(4)43-30)46(49)26-13-11-22(18-27(26)50-35(36,37)38)32(47)40-24-14-16-44(3)17-15-24/h7-9,11,13,18-19,24,49H,5-6,10,12,14-17H2,1-4H3,(H,40,47)(H,41,48)
InChIKeyUUZQSIXEGDUCTJ-UHFFFAOYSA-N
MW692.74 g/mol
LogP5.60
Rot. Bonds9

About N-(2,6-diethylphenyl)-8-[N-hydroxy-4-[(1-methylpiperidin-4-yl)carbamoyl]-2-(trifluoromethoxy)anilino]-1-methyl-4,5-dihydropyrazolo[4,5-h]quinazoline-3-carboxamide

N-(2,6-diethylphenyl)-8-[N-hydroxy-4-[(1-methylpiperidin-4-yl)carbamoyl]-2-(trifluoromethoxy)anilino]-1-methyl-4,5-dihydropyrazolo[4,5-h]quinazoline-3-carboxamide (PubChem CID 170168513) has the molecular formula C35H39F3N8O4 and a molecular weight of 692.74 g/mol. Its IUPAC name is N-(2,6-diethylphenyl)-8-[N-hydroxy-4-[(1-methylpiperidin-4-yl)carbamoyl]-2-(trifluoromethoxy)anilino]-1-methyl-4,5-dihydropyrazolo[4,5-h]quinazoline-3-carboxamide.

Molecular Properties

Compound NameN-(2,6-diethylphenyl)-8-[N-hydroxy-4-[(1-methylpiperidin-4-yl)carbamoyl]-2-(trifluoromethoxy)anilino]-1-methyl-4,5-dihydropyrazolo[4,5-h]quinazoline-3-carboxamide
PubChem CID170168513
Molecular FormulaC35H39F3N8O4
Molecular Weight692.74 g/mol
Exact Mass692.30
IUPAC NameN-(2,6-diethylphenyl)-8-[N-hydroxy-4-[(1-methylpiperidin-4-yl)carbamoyl]-2-(trifluoromethoxy)anilino]-1-methyl-4,5-dihydropyrazolo[4,5-h]quinazoline-3-carboxamide
SMILESCCc1cccc(CC)c1NC(=O)c1nn(C)c2c1CCc1cnc(N(O)c3ccc(C(=O)NC4CCN(C)CC4)cc3OC(F)(F)F)nc1-2
InChIInChI=1S/C35H39F3N8O4/c1-5-20-8-7-9-21(6-2)28(20)41-33(48)30-25-12-10-23-19-39-34(42-29(23)31(25)45(4)43-30)46(49)26-13-11-22(18-27(26)50-35(36,37)38)32(47)40-24-14-16-44(3)17-15-24/h7-9,11,13,18-19,24,49H,5-6,10,12,14-17H2,1-4H3,(H,40,47)(H,41,48)
InChIKeyUUZQSIXEGDUCTJ-UHFFFAOYSA-N
XLogP5.60
TPSA137.74 Ų
H-Bond Donors3
H-Bond Acceptors10
Rotatable Bonds9
Heavy Atoms50
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500692.74
LogP ≤ 55.60
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze N-(2,6-diethylphenyl)-8-[N-hydroxy-4-[(1-methylpiperidin-4-yl)carbamoyl]-2-(trifluoromethoxy)anilino]-1-methyl-4,5-dihydropyrazolo[4,5-h]quinazoline-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-(2,6-diethylphenyl)-8-[N-hydroxy-4-[(1-methylpiperidin-4-yl)carbamoyl]-2-(trifluoromethoxy)anilino]-1-methyl-4,5-dihydropyrazolo[4,5-h]quinazoline-3-carboxamide?
The IUPAC name of N-(2,6-diethylphenyl)-8-[N-hydroxy-4-[(1-methylpiperidin-4-yl)carbamoyl]-2-(trifluoromethoxy)anilino]-1-methyl-4,5-dihydropyrazolo[4,5-h]quinazoline-3-carboxamide (CID 170168513) is N-(2,6-diethylphenyl)-8-[N-hydroxy-4-[(1-methylpiperidin-4-yl)carbamoyl]-2-(trifluoromethoxy)anilino]-1-methyl-4,5-dihydropyrazolo[4,5-h]quinazoline-3-carboxamide.
What is the SMILES notation for N-(2,6-diethylphenyl)-8-[N-hydroxy-4-[(1-methylpiperidin-4-yl)carbamoyl]-2-(trifluoromethoxy)anilino]-1-methyl-4,5-dihydropyrazolo[4,5-h]quinazoline-3-carboxamide?
The canonical SMILES for N-(2,6-diethylphenyl)-8-[N-hydroxy-4-[(1-methylpiperidin-4-yl)carbamoyl]-2-(trifluoromethoxy)anilino]-1-methyl-4,5-dihydropyrazolo[4,5-h]quinazoline-3-carboxamide is CCc1cccc(CC)c1NC(=O)c1nn(C)c2c1CCc1cnc(N(O)c3ccc(C(=O)NC4CCN(C)CC4)cc3OC(F)(F)F)nc1-2.
What is the InChIKey of N-(2,6-diethylphenyl)-8-[N-hydroxy-4-[(1-methylpiperidin-4-yl)carbamoyl]-2-(trifluoromethoxy)anilino]-1-methyl-4,5-dihydropyrazolo[4,5-h]quinazoline-3-carboxamide?
The InChIKey is UUZQSIXEGDUCTJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C35H39F3N8O4/c1-5-20-8-7-9-21(6-2)28(20)41-33(48)30-25-12-10-23-19-39-34(42-29(23)31(25)45(4)43-30)46(49)26-13-11-22(18-27(26)50-35(36,37)38)32(47)40-24-14-16-44(3)17-15-24/h7-9,11,13,18-19,24,49H,5-6,10,12,14-17H2,1-4H3,(H,40,47)(H,41,48).
What are the key properties of N-(2,6-diethylphenyl)-8-[N-hydroxy-4-[(1-methylpiperidin-4-yl)carbamoyl]-2-(trifluoromethoxy)anilino]-1-methyl-4,5-dihydropyrazolo[4,5-h]quinazoline-3-carboxamide?
N-(2,6-diethylphenyl)-8-[N-hydroxy-4-[(1-methylpiperidin-4-yl)carbamoyl]-2-(trifluoromethoxy)anilino]-1-methyl-4,5-dihydropyrazolo[4,5-h]quinazoline-3-carboxamide has a molecular weight of 692.74 g/mol, XLogP of 5.60, 9 rotatable bonds, 3 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for N-(2,6-diethylphenyl)-8-[N-hydroxy-4-[(1-methylpiperidin-4-yl)carbamoyl]-2-(trifluoromethoxy)anilino]-1-methyl-4,5-dihydropyrazolo[4,5-h]quinazoline-3-carboxamide is sourced from PubChem (CID 170168513), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).